Market Place
Sourcing Support
Assembly Bio Reports Q3 2024 Financial Results & Recent Updates
07 Nov 2024 //
GLOBENEWSWIRE
Assembly Bio Reports Positive Phase 1a ABI-5366 Results
23 Sep 2024 //
GLOBENEWSWIRE
Assembly Biosciences Reports Q2 2024 Results And Recent Updates
08 Aug 2024 //
GLOBENEWSWIRE
Assembly Doses First Participant In Phase 1b Trial For ABI-4334 In Hepatitis B
18 Jun 2024 //
GLOBENEWSWIRE
Assembly Biosciences Announces $12.6 Million In Equity Financings
17 Jun 2024 //
GLOBENEWSWIRE
Assembly Doses First Patient With HSV Helicase Inhibitor ABI-5366
10 Jun 2024 //
GLOBENEWSWIRE
Atea: Positive Initial Phase 2 Bemnifosbuvir+Ruzasvir Data In HCV At EASL
05 Jun 2024 //
GLOBENEWSWIRE
Assembly Bio Data At Herpesvirus, EASL 2024 Meetings
22 May 2024 //
GLOBENEWSWIRE
Assembly Bio Q1 2024 Results, Recent Highlights
08 May 2024 //
GLOBENEWSWIRE
Assembly Biosciences Reports Fourth Quarter and Year End 2023 Financial Results
28 Mar 2024 //
GLOBENEWSWIRE
Assembly Biosciences Announces Effective Date of Reverse Stock Split
08 Feb 2024 //
GLOBENEWSWIRE
Assembly Biosciences Provides Anticipated Development Milestones for 2024
04 Jan 2024 //
GLOBENEWSWIRE
Assembly Biosciences Presents New Data Highlighting Viral Hepatitis Portfolio
10 Nov 2023 //
GLOBENEWSWIRE
Assembly Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
10 Nov 2023 //
GLOBENEWSWIRE
Assembly Biosciences Names Anuj Gaggar, MD, PhD, as Chief Medical Officer
08 Nov 2023 //
GLOBENEWSWIRE
Assembly Bio Reports Third Quarter 2023 Financial Results and Recent Updates
08 Nov 2023 //
GLOBENEWSWIRE
Gilead inks long-term antiviral drug pact with Assembly Bio
18 Oct 2023 //
PRESS RELEASE
Assembly Biosciences to Present New Data at AASLD The Liver Meeting®
11 Oct 2023 //
GLOBENEWSWIRE
Assembly Biosciences Nominates Development Candidate ABI-6250
02 Oct 2023 //
GLOBENEWSWIRE
Assembly Biosciences to Highlight Pipeline Progress in HBV and HDV
19 Sep 2023 //
GLOBENEWSWIRE
Assembly Bio Reports Second Quarter 2023 Financial Results and Recent Updates
09 Aug 2023 //
GLOBENEWSWIRE
Assembly Bio Presents Data Highlighting Herpes Simplex Virus Development Candidate ABI-5366
17 Jul 2023 //
GLOBENEWSWIRE
Assembly Biosciences Presents New Data Highlighting Entry Inhibitor & Programs
21 Jun 2023 //
GLOBENEWSWIRE
Assembly to Present Data at Upcoming International Herpesvirus Workshop
07 Jun 2023 //
GLOBENEWSWIRE
Assembly Biosciences to Present During the 2023 Jefferies Healthcare Conference
23 May 2023 //
GLOBENEWSWIRE
Assembly Biosciences Reports 1Q FYR 2023 and Recent Highlights
04 May 2023 //
GLOBENEWSWIRE
Assembly`s line of core inhibitors wobbles on the conveyor belt
19 Apr 2023 //
FIERCE BIOTECH
Assembly Announces Additional Promising Data from Phase 1a Trial ABI-4334
18 Apr 2023 //
GLOBENEWSWIRE
Assembly, Context and Innate add to pile of dumped R&D prospects
23 Mar 2023 //
FIERCE BIOTECH
Assembly Biosciences Reports Fourth Quarter and Year End 2022 Financial Results
22 Mar 2023 //
GLOBENEWSWIRE
Assembly Biosciences Nominates First Herpesvirus Development Candidate ABI-5366
15 Feb 2023 //
GLOBENEWSWIRE
Assembly Announces Promising Results from Trials Evaluating ABI-H3733 & ABI-4334
19 Dec 2022 //
GLOBENEWSWIRE
Emerging from hepatitis B flops, Assembly Bio showcases data on next-gen drugs
19 Dec 2022 //
ENDPTS
Emerging from hepatitis B flops, Assembly Bio showcases data on next-gen drugs
19 Dec 2022 //
ENDPTS
Assembly Doses First Subject in Ph1a Trial to Evaluate Safety, ABI-4334
14 Nov 2022 //
GLOBENEWSWIRE
Assembly Biosciences Reports3Q 2022 Financial Results and Recent Highlights
08 Nov 2022 //
GLOBENEWSWIRE
Assembly Biosciences Presents New Data at AASLD The Liver Meeting®
04 Nov 2022 //
GLOBENEWSWIRE
Assembly to Present Data in Four Poster Presentations
24 Oct 2022 //
GLOBENEWSWIRE
John McHutchison picks his `strategic partner` to run Assembly Bio
06 Oct 2022 //
ENPTS
Assembly Bio Announces Retirement of John G. McHutchison, AO, MD as CEO
05 Oct 2022 //
GLOBENEWSWIRE
Assembly to Host Webcast, Introducing Two New Research Programs
24 Aug 2022 //
GLOBENEWSWIRE
Assembly Biosciences Reports Q2 2022 Financial Results and Recent Highlights
09 Aug 2022 //
GLOBENEWSWIRE
Functional cure setback triggers layoffs at Assembly
21 Jul 2022 //
FIERCEBIOTECH
Assembly Bio Announces Program Reprioritization and Organizational Update
20 Jul 2022 //
GLOBENEWSWIRE
Assembly Biosciences Presents New Data Highlighting Clinical Progress at EASL
22 Jun 2022 //
GLOBENEWSWIRE
Assembly Bio to Highlight Data from HBV Core Inhibitor Programs at EASL 2022
08 Jun 2022 //
GLOBENEWSWIRE
Assembly Biosciences Initiates PIb Trial Evaluating ABI-H3733 for Hepatitis B
06 Jun 2022 //
GLOBENEWSWIRE
Assembly Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
03 Jun 2022 //
GLOBENEWSWIRE
FDA Puts Clinical Hold on Antios` HBV Therapy, Ends Collaboration with Assembly
01 Jun 2022 //
TRIALSITENEWS
Heart trouble report & clinical hold spell end of Antios, Assembly Bio alliance
26 May 2022 //
MEDCITYNEWS
Assembly Biosciences Reports First Quarter 2022 Financial Results
12 May 2022 //
GLOBENEWSWIRE
Assembly Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
01 Apr 2022 //
GLOBENEWSWIRE
Assembly Bio to Highlight New Research Program for HBV/HDV Entry Inhibition
21 Mar 2022 //
GLOBENEWSWIRE
Assembly Bio Reports Q4 and Year End 2021 Financial Results
10 Mar 2022 //
GLOBENEWSWIRE
Assembly Biosciences to Present During the SVB Leerink 11th Annual Conference
09 Feb 2022 //
GLOBENEWSWIRE
Assembly Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
07 Jan 2022 //
GLOBENEWSWIRE
Assembly Biosciences to present at 2022 H.C. Wainwright Virtual Conference
06 Jan 2022 //
GLOBENEWSWIRE
Assembly Biosciences Outlines Anticipated 2022 Pipeline Development Milestones
04 Jan 2022 //
GLOBENEWSWIRE
Assembly Biosciences Outlines Anticipated 2022 Pipeline Development Milestones
04 Jan 2022 //
BIOSPACE
Assembly Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
03 Dec 2021 //
GLOBENEWSWIRE
